These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21531813)

  • 1. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
    Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
    Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer.
    Dong W; Li H; Zhang Y; Yang H; Guo M; Li L; Liu T
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):840-8. PubMed ID: 21968416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer.
    Segelman J; Singnomklao T; Hellborg H; Martling A
    Colorectal Dis; 2009 Sep; 11(7):768-74. PubMed ID: 18662241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
    Kim J; Takeuchi H; Lam ST; Turner RR; Wang HJ; Kuo C; Foshag L; Bilchik AJ; Hoon DS
    J Clin Oncol; 2005 Apr; 23(12):2744-53. PubMed ID: 15837989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene signature is associated with early stage rectal cancer recurrence.
    Kalady MF; Dejulius K; Church JM; Lavery IC; Fazio VW; Ishwaran H
    J Am Coll Surg; 2010 Aug; 211(2):187-95. PubMed ID: 20670856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival in colorectal cancer patients.
    Laohavinij S; Maneechavakajorn J; Techatanol P
    J Med Assoc Thai; 2010 Oct; 93(10):1156-66. PubMed ID: 20973318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
    Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
    Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer.
    Huang MY; Wang JY; Chang HJ; Kuo CW; Tok TS; Lin SR
    Oncol Rep; 2011 May; 25(5):1297-306. PubMed ID: 21344162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark.
    Korsgaard M; Pedersen L; Sørensen HT; Laurberg S
    Colorectal Dis; 2006 Oct; 8(8):688-95. PubMed ID: 16970580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
    Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients.
    Shen YM; Arbman G; Sandström P; Gullstrand P; Wei YQ; Zhang H; Rosell J; Olsson B; Peng F; Yang HS; Wang CT; Sun XF
    Oncol Rep; 2012 Feb; 27(2):376-82. PubMed ID: 22024937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.
    Lemmens V; van Steenbergen L; Janssen-Heijnen M; Martijn H; Rutten H; Coebergh JW
    Acta Oncol; 2010 Aug; 49(6):784-96. PubMed ID: 20429731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage II/III cancer of the rectosigmoid junction: an independent tumor type?
    Mukai M; Kishima K; Yamazaki M; Aoki H; Izumi H; Yamamoto S; Tajima T; Tobita K; Sadahiro S; Yasuda S; Ogoshi K
    Oncol Rep; 2011 Sep; 26(3):737-41. PubMed ID: 21667035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer.
    Vermeulen PB; Van den Eynden GG; Huget P; Goovaerts G; Weyler J; Lardon F; Van Marck E; Hubens G; Dirix LY
    Br J Cancer; 1999 Jan; 79(2):316-22. PubMed ID: 9888475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of molecular marker expression can predict clinical outcome in colon carcinomas.
    Galizia G; Lieto E; Ferraraccio F; Orditura M; De Vita F; Castellano P; Imperatore V; Romano C; Ciardiello F; Agostini B; Pignatelli C
    Clin Cancer Res; 2004 May; 10(10):3490-9. PubMed ID: 15161706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.